Prospective Evaluation of MGMT -Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
Brighi, Nicole, Lamberti, Giuseppe, Andrini, Elisa, Mosconi, Cristina, Manuzzi, Lisa, Donati, Giada, Lisotti, Andrea, Campana, Davide
Published in Current oncology (Toronto) (18.01.2023)
Published in Current oncology (Toronto) (18.01.2023)
Get full text
Journal Article
IMpower 132: Is the Second Exception to the Rule No Longer an Exception?
Di Federico, Alessandro, Nuvola, Giacomo, Deiana, Chiara, Donati, Giada, De Giglio, Andrea
Published in Journal of thoracic oncology (01.05.2021)
Published in Journal of thoracic oncology (01.05.2021)
Get full text
Journal Article
The prognostic role of body-mass index (BMI) for advanced EGFR positive non-small cell lung cancer (NSCLC) patients treated with osimertinib
De Giglio, Andrea, Di Federico, Alessandro, Donati, Giada, Deiana, Chiara, Nuvola, Giacomo, Fragomeno, Benedetta, Sperandi, Francesca, Melotti, Barbara, Gelsomino, Francesco, Ardizzoni, Andrea
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Prospective Evaluation of IMGMT/I-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
Brighi, Nicole, Lambe, Andrini, Elisa, Mosconi, Cristina, Manuzzi, Lisa, Donati, Giada, Lisotti, Andrea, Campana, Davide
Published in Current oncology (Toronto) (01.01.2023)
Published in Current oncology (Toronto) (01.01.2023)
Get full text
Journal Article